Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Dissecting the mechanism of action of actinoporins. Role of the N-terminal amphipathic α-helix in membrane binding and pore activity of sticholysins I and II.

Carretero GPB, Vicente EF, Cilli EM, Alvarez CM, Jenssen H, Schreier S.

PLoS One. 2018 Aug 30;13(8):e0202981. doi: 10.1371/journal.pone.0202981. eCollection 2018.

2.

Optimized Scratch Assay for In Vitro Testing of Cell Migration with an Automated Optical Camera.

Vang Mouritzen M, Jenssen H.

J Vis Exp. 2018 Aug 8;(138). doi: 10.3791/57691.

PMID:
30148500
3.

7th International Meeting on Antimicrobial Peptides.

Jenssen H.

J Pept Sci. 2018 Jul;24(7):e3116. doi: 10.1002/psc.3116. No abstract available.

PMID:
30133959
4.

Biofilm production and antibiotic susceptibility of Staphylococcus epidermidis strains from Hidradenitis Suppurativa lesions.

Ardon CB, Prens EP, Fuursted K, Ejaz RN, Shailes J, Jenssen H, Jemec GBE.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):170-177. doi: 10.1111/jdv.15183. Epub 2018 Aug 7.

PMID:
30022542
5.

Neurotensin, substance P, and insulin enhance cell migration.

Mouritzen MV, Abourayale S, Ejaz R, Ardon CB, Carvalho E, Dalgaard LT, Roursgaard M, Jenssen H.

J Pept Sci. 2018 Jul;24(7):e3093. doi: 10.1002/psc.3093. Epub 2018 Jun 25.

PMID:
29938867
6.

A near full-length open reading frame next generation sequencing assay for genotyping and identification of resistance-associated variants in hepatitis C virus.

Pedersen MS, Fahnøe U, Hansen TA, Pedersen AG, Jenssen H, Bukh J, Schønning K.

J Clin Virol. 2018 Aug;105:49-56. doi: 10.1016/j.jcv.2018.05.012. Epub 2018 Jun 1.

PMID:
29886373
7.

Antibiofilm Peptides and Peptidomimetics with Focus on Surface Immobilization.

Andrea A, Molchanova N, Jenssen H.

Biomolecules. 2018 May 16;8(2). pii: E27. doi: 10.3390/biom8020027. Review.

8.

LL-37 fragments have antimicrobial activity against Staphylococcus epidermidis biofilms and wound healing potential in HaCaT cell line.

Saporito P, Vang Mouritzen M, Løbner-Olesen A, Jenssen H.

J Pept Sci. 2018 Jul;24(7):e3080. doi: 10.1002/psc.3080. Epub 2018 May 8.

PMID:
29737589
9.
10.

A Novel pAA Virulence Plasmid Encoding Toxins and Two Distinct Variants of the Fimbriae of Enteroaggregative Escherichia coli.

Jønsson R, Struve C, Boll EJ, Boisen N, Joensen KG, Sørensen CA, Jensen BH, Scheutz F, Jenssen H, Krogfelt KA.

Front Microbiol. 2017 Feb 22;8:263. doi: 10.3389/fmicb.2017.00263. eCollection 2017.

11.

Peptoids successfully inhibit the growth of gram negative E. coli causing substantial membrane damage.

Mojsoska B, Carretero G, Larsen S, Mateiu RV, Jenssen H.

Sci Rep. 2017 Feb 14;7:42332. doi: 10.1038/srep42332.

12.

Improving heterologous production of phenylpropanoids in Saccharomyces cerevisiae by tackling an unwanted side reaction of Tsc13, an endogenous double-bond reductase.

Lehka BJ, Eichenberger M, Bjørn-Yoshimoto WE, Vanegas KG, Buijs N, Jensen NB, Dyekjær JD, Jenssen H, Simon E, Naesby M.

FEMS Yeast Res. 2017 Jan 1;17(1). doi: 10.1093/femsyr/fox004.

13.

Structural and functional studies of Escherichia coli aggregative adherence fimbriae (AAF/V) reveal a deficiency in extracellular matrix binding.

Jønsson R, Liu B, Struve C, Yang Y, Jørgensen R, Xu Y, Jenssen H, Krogfelt KA, Matthews S.

Biochim Biophys Acta Proteins Proteom. 2017 Mar;1865(3):304-311. doi: 10.1016/j.bbapap.2016.11.017. Epub 2016 Dec 9.

14.

The wax moth Galleria mellonella as a novel model system to study Enteroaggregative Escherichia coli pathogenesis.

Jønsson R, Struve C, Jenssen H, Krogfelt KA.

Virulence. 2017 Nov 17;8(8):1894-1899. doi: 10.1080/21505594.2016.1256537. Epub 2017 Oct 19. No abstract available.

15.

The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300.

Thomsen TT, Mojsoska B, Cruz JC, Donadio S, Jenssen H, Løbner-Olesen A, Rewitz K.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5427-36. doi: 10.1128/AAC.02965-15. Print 2016 Sep.

16.

In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents.

Czyzewski AM, Jenssen H, Fjell CD, Waldbrook M, Chongsiriwatana NP, Yuen E, Hancock RE, Barron AE.

PLoS One. 2016 Feb 5;11(2):e0135961. doi: 10.1371/journal.pone.0135961. eCollection 2016.

17.

Antimicrobial activity of GN peptides and their mode of action.

Godballe T, Mojsoska B, Nielsen HM, Jenssen H.

Biopolymers. 2016 Mar;106(2):172-183. doi: 10.1002/bip.22796.

PMID:
26662856
18.

Results of a Direct Search Using Synchrotron Radiation for the Low-Energy (229)Th Nuclear Isomeric Transition.

Jeet J, Schneider C, Sullivan ST, Rellergert WG, Mirzadeh S, Cassanho A, Jenssen HP, Tkalya EV, Hudson ER.

Phys Rev Lett. 2015 Jun 26;114(25):253001. Epub 2015 Jun 23.

PMID:
26197124
19.

Peptides and Peptidomimetics for Antimicrobial Drug Design.

Mojsoska B, Jenssen H.

Pharmaceuticals (Basel). 2015 Jul 13;8(3):366-415. doi: 10.3390/ph8030366. Review.

20.

The bacteriology of hidradenitis suppurativa: a systematic review.

Ring HC, Riis Mikkelsen P, Miller IM, Jenssen H, Fuursted K, Saunte DM, Jemec GB.

Exp Dermatol. 2015 Oct;24(10):727-31. doi: 10.1111/exd.12793. Epub 2015 Aug 21. Review.

PMID:
26119625
21.

Structure-activity relationship study of novel peptoids that mimic the structure of antimicrobial peptides.

Mojsoska B, Zuckermann RN, Jenssen H.

Antimicrob Agents Chemother. 2015 Jul;59(7):4112-20. doi: 10.1128/AAC.00237-15. Epub 2015 May 4.

22.

Novel aggregative adherence fimbria variant of enteroaggregative Escherichia coli.

Jønsson R, Struve C, Boisen N, Mateiu RV, Santiago AE, Jenssen H, Nataro JP, Krogfelt KA.

Infect Immun. 2015 Apr;83(4):1396-405. doi: 10.1128/IAI.02820-14. Epub 2015 Jan 26.

23.

Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice.

Shestakov A, Jenssen H, Hancock RE, Nordström I, Eriksson K.

Antiviral Res. 2013 Nov;100(2):455-9. doi: 10.1016/j.antiviral.2013.08.019. Epub 2013 Sep 5.

PMID:
24012999
24.

Biochemical signs of impaired cobalamin function do not affect hematological parameters in young infants: results from a double-blind randomized controlled trial.

Jenssen HB, Torsvik I, Ueland PM, Midttun Ø, Bjørke-Monsen AL.

Pediatr Res. 2013 Sep;74(3):327-32. doi: 10.1038/pr.2013.101. Epub 2013 Jun 14.

PMID:
23770919
25.

Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory.

Kindrachuk J, Jenssen H, Elliott M, Nijnik A, Magrangeas-Janot L, Pasupuleti M, Thorson L, Ma S, Easton DM, Bains M, Finlay B, Breukink EJ, Georg-Sahl H, Hancock RE.

Innate Immun. 2013 Jun;19(3):315-27. doi: 10.1177/1753425912461456. Epub 2012 Oct 29.

PMID:
23109507
26.

The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS.

Fernández L, Jenssen H, Bains M, Wiegand I, Gooderham WJ, Hancock RE.

Antimicrob Agents Chemother. 2012 Dec;56(12):6212-22. doi: 10.1128/AAC.01530-12. Epub 2012 Sep 24.

27.

Hyperactive antifreeze proteins from longhorn beetles: some structural insights.

Kristiansen E, Wilkens C, Vincents B, Friis D, Lorentzen AB, Jenssen H, Løbner-Olesen A, Ramløv H.

J Insect Physiol. 2012 Nov;58(11):1502-10. doi: 10.1016/j.jinsphys.2012.09.004. Epub 2012 Sep 21.

PMID:
23000739
28.

Human cathelicidin LL-37 prevents bacterial biofilm formation.

Jacobsen AS, Jenssen H.

Future Med Chem. 2012 Aug;4(12):1587-99. doi: 10.4155/fmc.12.97. Review.

PMID:
22917247
29.

Innate defense regulator peptide 1018 in wound healing and wound infection.

Steinstraesser L, Hirsch T, Schulte M, Kueckelhaus M, Jacobsen F, Mersch EA, Stricker I, Afacan N, Jenssen H, Hancock RE, Kindrachuk J.

PLoS One. 2012;7(8):e39373. doi: 10.1371/journal.pone.0039373. Epub 2012 Aug 6.

30.

Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice.

Shestakov A, Jenssen H, Nordström I, Eriksson K.

Antiviral Res. 2012 Mar;93(3):340-5. doi: 10.1016/j.antiviral.2012.01.003. Epub 2012 Jan 16.

PMID:
22269645
31.

Quantitative structure-activity relationships and docking studies of calcitonin gene-related peptide antagonists.

Kyani A, Mehrabian M, Jenssen H.

Chem Biol Drug Des. 2012 Feb;79(2):166-76. doi: 10.1111/j.1747-0285.2011.01252.x. Epub 2011 Nov 24.

PMID:
21974743
32.

Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival.

Lynn MA, Kindrachuk J, Marr AK, Jenssen H, Panté N, Elliott MR, Napper S, Hancock RE, McMaster WR.

PLoS Negl Trop Dis. 2011;5(5):e1141. doi: 10.1371/journal.pntd.0001141. Epub 2011 May 31.

33.

Descriptors for antimicrobial peptides.

Jenssen H.

Expert Opin Drug Discov. 2011 Feb;6(2):171-84. doi: 10.1517/17460441.2011.545817. Epub 2011 Jan 5.

PMID:
22647135
34.

Antimicrobial β-peptides and α-peptoids.

Godballe T, Nilsson LL, Petersen PD, Jenssen H.

Chem Biol Drug Des. 2011 Feb;77(2):107-16. doi: 10.1111/j.1747-0285.2010.01067.x. Review.

PMID:
21266014
35.

Importance of residue 13 and the C-terminus for the structure and activity of the antimicrobial peptide aurein 2.2.

Cheng JT, Hale JD, Kindrachuk J, Jenssen H, Elliott M, Hancock RE, Straus SK.

Biophys J. 2010 Nov 3;99(9):2926-35. doi: 10.1016/j.bpj.2010.08.077. Erratum in: Biophys J. 2010 Dec 15;99(12):4078. Jessen, Havard [corrected to Jenssen, Håvard].

36.

Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections.

Kazemzadeh-Narbat M, Kindrachuk J, Duan K, Jenssen H, Hancock RE, Wang R.

Biomaterials. 2010 Dec;31(36):9519-26. doi: 10.1016/j.biomaterials.2010.08.035.

PMID:
20970848
37.

Optimization of antibacterial peptides by genetic algorithms and cheminformatics.

Fjell CD, Jenssen H, Cheung WA, Hancock RE, Cherkasov A.

Chem Biol Drug Des. 2011 Jan;77(1):48-56. doi: 10.1111/j.1747-0285.2010.01044.x. Epub 2010 Oct 13.

PMID:
20942839
38.

Structural studies of a peptide with immune modulating and direct antimicrobial activity.

Wieczorek M, Jenssen H, Kindrachuk J, Scott WR, Elliott M, Hilpert K, Cheng JT, Hancock RE, Straus SK.

Chem Biol. 2010 Sep 24;17(9):970-80. doi: 10.1016/j.chembiol.2010.07.007.

39.

Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli.

Bommarius B, Jenssen H, Elliott M, Kindrachuk J, Pasupuleti M, Gieren H, Jaeger KE, Hancock RE, Kalman D.

Peptides. 2010 Nov;31(11):1957-65. doi: 10.1016/j.peptides.2010.08.008. Epub 2010 Aug 14.

40.

Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment.

Nijnik A, Madera L, Ma S, Waldbrook M, Elliott MR, Easton DM, Mayer ML, Mullaly SC, Kindrachuk J, Jenssen H, Hancock RE.

J Immunol. 2010 Mar 1;184(5):2539-50. doi: 10.4049/jimmunol.0901813. Epub 2010 Jan 27.

41.

Therapeutic potential of HDPs as immunomodulatory agents.

Jenssen H, Hancock RE.

Methods Mol Biol. 2010;618:329-47. doi: 10.1007/978-1-60761-594-1_20.

PMID:
20094873
42.

Therapeutic approaches using host defence peptides to tackle herpes virus infections.

Jenssen H.

Viruses. 2009 Dec;1(3):939-64. doi: 10.3390/v1030939. Epub 2009 Nov 18.

43.

A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity.

Kindrachuk J, Jenssen H, Elliott M, Townsend R, Nijnik A, Lee SF, Gerdts V, Babiuk LA, Halperin SA, Hancock RE.

Vaccine. 2009 Jul 23;27(34):4662-71. doi: 10.1016/j.vaccine.2009.05.094. Epub 2009 Jun 17.

PMID:
19539585
44.

The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice.

Kovacs-Nolan J, Latimer L, Landi A, Jenssen H, Hancock RE, Babiuk LA, van Drunen Littel-van den Hurk S.

Vaccine. 2009 Mar 23;27(14):2055-64. doi: 10.1016/j.vaccine.2009.01.118. Epub 2009 Feb 2.

PMID:
19428830
45.

Identification of novel antibacterial peptides by chemoinformatics and machine learning.

Fjell CD, Jenssen H, Hilpert K, Cheung WA, Panté N, Hancock RE, Cherkasov A.

J Med Chem. 2009 Apr 9;52(7):2006-15. doi: 10.1021/jm8015365.

PMID:
19296598
46.

Screening and characterization of surface-tethered cationic peptides for antimicrobial activity.

Hilpert K, Elliott M, Jenssen H, Kindrachuk J, Fjell CD, Körner J, Winkler DF, Weaver LL, Henklein P, Ulrich AS, Chiang SH, Farmer SW, Pante N, Volkmer R, Hancock RE.

Chem Biol. 2009 Jan 30;16(1):58-69. doi: 10.1016/j.chembiol.2008.11.006.

47.

Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs.

Cherkasov A, Hilpert K, Jenssen H, Fjell CD, Waldbrook M, Mullaly SC, Volkmer R, Hancock RE.

ACS Chem Biol. 2009 Jan 16;4(1):65-74. doi: 10.1021/cb800240j.

PMID:
19055425
48.

Novel anti-infectives: is host defence the answer?

Hamill P, Brown K, Jenssen H, Hancock RE.

Curr Opin Biotechnol. 2008 Dec;19(6):628-36. doi: 10.1016/j.copbio.2008.10.006. Epub 2008 Nov 25. Review.

PMID:
19000763
49.

Serum stability of peptides.

Jenssen H, Aspmo SI.

Methods Mol Biol. 2008;494:177-86. doi: 10.1007/978-1-59745-419-3_10.

PMID:
18726574
50.

Antimicrobial properties of lactoferrin.

Jenssen H, Hancock RE.

Biochimie. 2009 Jan;91(1):19-29. doi: 10.1016/j.biochi.2008.05.015. Epub 2008 Jun 5. Review.

PMID:
18573312

Supplemental Content

Loading ...
Support Center